A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
Conditions: Uncomplicated Malaria; Asymptomatic Condition; Falciparum Malaria Interventions: Drug: ZY19489 + Ferroquine (FQ); Drug: Placebo Sponsor: Zydus Lifesciences Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials